ArticleBMC veterinary research2025
Development of an indirect ELISA for Duck circovirus detection based on prokaryotically expressed antigen.
Article in BMC veterinary research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Overview of waterfowl circovirus: research progress and future perspectives.Frontiers in veterinary science · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
Abstract
Duck circovirus (DuCV) is an immunosuppressive virus that primarily causes growth retardation and immunosuppression in infected ducks, often leading to secondary infections, thereby posing a serious threat to the global duck industry. Currently, most indirect ELISA assays for DuCV rely on antibodies targeting the Cap structural protein; however, these methods cannot distinguish between antibodies generated by natural infection and those induced by vaccination. In this study, the Rep non-structural protein and truncated Cap structural protein lacking the nuclear localization signal (ΔCap) were successfully expressed using a prokaryotic Escherichia coli expression system. Two indirect ELISA methods were developed using the two proteins as coating antigens, and the method conditions were further optimized. The results demonstrated that both the Rep-ELISA and ΔCap-ELISA exhibited high specificity and sensitivity. When applied to duck serum samples from parts of Shandong Province, the correlation rates between the ELISA and conventional PCR methods were 95.5% and 93.3%, respectively. Furthermore, the positive detection rates in sera from vaccinated ducks were 10% for Rep-ELISA and 91% for ΔCap-ELISA, indicating that the ELISA method established in this study can differentiate between natural infection and vaccine immunization. This study provides a novel serological tool for epidemiological surveillance and vaccine evaluation of DuCV.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.